CAJ | 학술논문

肝脏是胃肠间质瘤(GIST)最常见的转移部位,即使行肝切除后,仍有较高的复发率.虽然酪氨酸激酶抑制剂(TKI)的出现使得许多GIST肝转移患者有了手术切除的可能并显著提高了生存率,但仍无法完全替代手术治疗.因此,GIST肝转移的患者如何才能获得最佳的治疗,值得进行深入的研究和探讨.
간장시위장간질류(GIST)최상견적전이부위,즉사행간절제후,잉유교고적복발솔.수연락안산격매억제제(TKI)적출현사득허다GIST간전이환자유료수술절제적가능병현저제고료생존솔,단잉무법완전체대수술치료.인차,GIST간전이적환자여하재능획득최가적치료,치득진행심입적연구화탐토.
Liver is the most common metastatic site of gastrointestinal stromal tumor(GIST).The recurrence rate is high even after hepatectomy. Although tyrosine kinase inhibitors (TKI) makes the resection feasible for some of the liver metastasis of GIST and significantly increase the overall survival,surgery still can not be substituted.Therefore,it is worth investigating and exploring the most appropriate treatment for the GIST with liver metastasis.